Rangeley Capital, LLC Essa Pharma Inc. Transaction History
Rangeley Capital, LLC
- $83.8 Billion
- Q2 2025
A detailed history of Rangeley Capital, LLC transactions in Essa Pharma Inc. stock. As of the latest transaction made, Rangeley Capital, LLC holds 170,000 shares of EPIX stock, worth $324,700. This represents 0.34% of its overall portfolio holdings.
Number of Shares
170,000Holding current value
$324,700% of portfolio
0.34%Shares
1 transactions
Others Institutions Holding EPIX
# of Institutions
43Shares Held
29MCall Options Held
445KPut Options Held
201K-
Bvf Inc San Francisco, CA8.75MShares$16.7 Million0.58% of portfolio
-
Tang Capital Management LLC San Diego, CA4.3MShares$8.21 Million0.44% of portfolio
-
Bml Capital Management, LLC Zionsville, IN4.22MShares$8.06 Million5.43% of portfolio
-
Morgan Stanley New York, NY4.21MShares$8.04 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.26MShares$4.32 Million0.3% of portfolio
About ESSA Pharma Inc.
- Ticker EPIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 44,073,100
- Market Cap $84.2M
- Description
- ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreem...